Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)

The article describes a clinical case of a progressive form of systemic scleroderma in a 39-year-old man. The patient has an acute course and rapid progression of the disease with a significant initial decrease in the forced vital capacity of the lungs, with signs of an unfavorable prognosis, such a...

Full description

Saved in:
Bibliographic Details
Main Authors: E. N. Harlamova, Ju. Ju. Karpenko
Format: Article
Language:Russian
Published: SINAPS LLC 2021-01-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/1123
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850026064070311936
author E. N. Harlamova
Ju. Ju. Karpenko
author_facet E. N. Harlamova
Ju. Ju. Karpenko
author_sort E. N. Harlamova
collection DOAJ
description The article describes a clinical case of a progressive form of systemic scleroderma in a 39-year-old man. The patient has an acute course and rapid progression of the disease with a significant initial decrease in the forced vital capacity of the lungs, with signs of an unfavorable prognosis, such as a diffuse form, a high skin count (> 14), male sex, and high positivity for antibodies to Scl-70. In connection with the ineffectiveness of standard therapy with glucocorticoids and immunosuppressants at an early stage of the disease, the option of treatment with genetically engineered drugs (rituximab) was considered. As a result of the therapy, a positive trend was noted.
format Article
id doaj-art-de9899d4bee94701a5d851d618da4f9d
institution DOAJ
issn 2226-6704
2411-6564
language Russian
publishDate 2021-01-01
publisher SINAPS LLC
record_format Article
series Архивъ внутренней медицины
spelling doaj-art-de9899d4bee94701a5d851d618da4f9d2025-08-20T03:00:39ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642021-01-01111727510.20514/2226-6704-2021-11-1-72-75829Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)E. N. Harlamova0Ju. Ju. Karpenko1State Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian FederationState Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian FederationThe article describes a clinical case of a progressive form of systemic scleroderma in a 39-year-old man. The patient has an acute course and rapid progression of the disease with a significant initial decrease in the forced vital capacity of the lungs, with signs of an unfavorable prognosis, such as a diffuse form, a high skin count (> 14), male sex, and high positivity for antibodies to Scl-70. In connection with the ineffectiveness of standard therapy with glucocorticoids and immunosuppressants at an early stage of the disease, the option of treatment with genetically engineered drugs (rituximab) was considered. As a result of the therapy, a positive trend was noted.https://www.medarhive.ru/jour/article/view/1123systemic sclerodermarituximabpoor prognosis
spellingShingle E. N. Harlamova
Ju. Ju. Karpenko
Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
Архивъ внутренней медицины
systemic scleroderma
rituximab
poor prognosis
title Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
title_full Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
title_fullStr Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
title_full_unstemmed Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
title_short Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
title_sort evaluation of the efficiency of treatment with rituximab for systemic scleroderma a case report
topic systemic scleroderma
rituximab
poor prognosis
url https://www.medarhive.ru/jour/article/view/1123
work_keys_str_mv AT enharlamova evaluationoftheefficiencyoftreatmentwithrituximabforsystemicsclerodermaacasereport
AT jujukarpenko evaluationoftheefficiencyoftreatmentwithrituximabforsystemicsclerodermaacasereport